| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2567.2008.02824.X |
| P698 | PubMed publication ID | 18312359 |
| P50 | author | Ernst Kuipers | Q39447567 |
| Luc J.W. van der Laan | Q59187940 | ||
| Jaap Kwekkeboom | Q91344273 | ||
| Herold J Metselaar | Q92961578 | ||
| Shanta Mancham | Q114258747 | ||
| P2093 | author name string | Roel de Haan | |
| Nicole M A Nagtzaam | |||
| Brenda M Bosma | |||
| P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
| Heterologous immunity provides a potent barrier to transplantation tolerance | Q35095576 | ||
| Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
| Memory T cells: a hurdle to immunologic tolerance | Q35205748 | ||
| Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction | Q35583516 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
| Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates | Q40779546 | ||
| IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. | Q40811244 | ||
| Differential effects of corticosteroids during different stages of dendritic cell maturation | Q40887640 | ||
| Regulation of cytokine and cytokine receptor expression by glucocorticoids | Q41224382 | ||
| Glucocorticoids and immune function: unknown dimensions and new frontiers | Q41591663 | ||
| Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. | Q41985283 | ||
| Inhibition of human dendritic cell functions by methylprednisolone. | Q42473073 | ||
| Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
| Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells | Q47288081 | ||
| Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. | Q51979644 | ||
| Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. | Q51982170 | ||
| Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo | Q59312658 | ||
| Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10 | Q59640223 | ||
| Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-γ-mediated signaling | Q61863501 | ||
| The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells | Q74164913 | ||
| Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential | Q77573844 | ||
| Glucocorticoids affect human dendritic cell differentiation and maturation | Q77823491 | ||
| Impairment of circulating myeloid dendritic cells in immunosuppressed liver transplant recipients | Q80654708 | ||
| Characterization of human liver dendritic cells in liver grafts and perfusates | Q82650070 | ||
| P433 | issue | 1 | |
| P921 | main subject | dendritic cell | Q506253 |
| lipopolysaccharide | Q421804 | ||
| dexamethasone | Q422252 | ||
| P304 | page(s) | 91-100 | |
| P577 | publication date | 2008-02-27 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells | |
| P478 | volume | 125 |
| Q42143137 | A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines. |
| Q92405168 | Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus? |
| Q40400106 | Downregulation of the Syk Signaling Pathway in Intestinal Dendritic Cells Is Sufficient To Induce Dendritic Cells That Inhibit Colitis. |
| Q26779413 | Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity |
| Q41180997 | Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. |
| Q26764855 | Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications |
| Q27687406 | Immunotherapy with myeloid cells for tolerance induction |
| Q64268046 | Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition - implications for the next generation of DC vaccines |
| Q49825029 | Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours |
| Q47325556 | Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment. |
| Q26866216 | Regulatory dendritic cells for immunotherapy in immunologic diseases |
| Q37505188 | Tolerogenic dendritic cells derived from donors with natural rubber latex allergy modulate allergen-specific T-cell responses and IgE production |
Search more.